Modulation of SIRT1 expression in different neurodegenerative models and human pathologies
about
Interactomic and pharmacological insights on human sirt-1Protective effects and mechanisms of sirtuins in the nervous systemThe role of mammalian sirtuins in the regulation of metabolism, aging, and longevitySirtuin Functions in Female Fertility: Possible Role in Oxidative Stress and AgingParkinson's disease as a result of agingSIRT1 is essential for normal cognitive function and synaptic plasticitySirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson's disease.Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.SIRT1 regulates dendritic development in hippocampal neurons.SIRT1 in the brain-connections with aging-associated disorders and lifespanSirtuins, aging, and cardiovascular risks.Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressorsActivation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.Sirtuin regulation in aging and injuryThe epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cellsGrowth hormone and melatonin prevent age-related alteration in apoptosis processes in the dentate gyrus of male ratsThe potential role of epigenetic modulations in BPPV maneuver exercises.Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise.Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targetsHDAC inhibitors and neurodegeneration: at the edge between protection and damage.Epigenetic treatment of neurological disease.Sirtuins: from metabolic regulation to brain aging.Neuroprotective effects of psychotropic drugs in Huntington's diseaseRole of Sirt1 during the ageing process: relevance to protection of synapses in the brain.Nutritional biomarkers: Current view and future perspectives.Could Sirtuin Activities Modify ALS Onset and Progression?Resveratrol inhibits proliferation and promotes apoptosis of neuroblastoma cells: role of sirtuin 1.Aging and vascular dysfunction: beneficial melatonin effects.Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.Transcriptional Response of Polycomb Group Genes to Status Epilepticus in Mice is Modified by Prior Exposure to Epileptic Preconditioning.Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.SIRT1 mediates salidroside-elicited protective effects against MPP+ -induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK pathways.SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Voluntary exercise promotes beneficial anti-aging mechanisms in SAMP8 female brain.Hydrogen sulfide attenuates chronic restrain stress-induced cognitive impairment by upreglulation of Sirt1 in hippocampus.A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia.Down-regulated miR-448 relieves spinal cord ischemia/reperfusion injury by up-regulating SIRT1.
P2860
Q21129288-FAF72060-EEE0-48FD-8BD8-F8A30B873A41Q26825585-FFC9B038-76EE-49CE-8788-47B3D1C5652AQ26865526-FA235F97-957E-44DE-A713-4D908B039DF3Q27021755-4A151038-20FA-4938-B4B1-27DAD612A73DQ28084395-7ACBB7B5-C91A-4092-BF52-CF407CE9E1E0Q30496047-E695DE34-4E6E-49FC-9564-54FF11799341Q33619317-8C00B823-5F92-42E9-8C5E-253661DF3BC2Q33755854-5E918971-64C2-4B2D-A518-5ACF2FDECFA2Q33986353-70DDC0F9-2D7C-4AE2-8752-1E9293460526Q34373713-5506F604-8644-4A79-971F-A57EE37B33BEQ34442806-B2F2A16E-160D-4AED-922E-6B334361C018Q35158382-9469DAFF-BF94-45DD-B79F-24684CDDCD48Q35768345-3B10DB55-DDD9-474D-A82E-5B019AE9B2A4Q36099563-0F2A9E4C-018B-4299-A37A-971B0B917CCAQ36288305-9681FA54-7611-4DAE-A39A-98AE16400A77Q36379286-1A249CDE-8DD3-487D-82E2-BE04D89E3A4DQ36614696-215CB8DA-A533-4361-AD46-B7DA838092BAQ37085886-31D1DF48-D612-420F-9DCB-39F9AC1246E4Q37392511-91940F25-071F-444F-8F0C-E73AE653C270Q37650337-88F9F6ED-59D4-497C-AAC7-5BA43F997F65Q37657902-F8C7116F-B8E7-4A9E-A770-9A294179601CQ37685428-1A5C5BA1-D70C-418F-9C9D-DD658A7F13ACQ37962584-5926C761-F7D0-41A4-800C-B62C680B45E6Q38124259-CCA8E261-4031-411C-AD4E-4652F1259EC9Q38163877-AC6C0F6A-0DB3-4536-9BA5-62A725B8223CQ38185276-A09BCCEC-99AA-4F1E-984D-2E3A7A51FE02Q38662575-C93BBDA4-79C1-4338-A96E-30AF753B6AC9Q39036105-1C4D77AA-E1B5-4DA2-B1BC-8505438EC827Q39640335-512AC317-CEF0-43FF-9516-C3A9F3655DD1Q41814482-3E6CC44D-5FAF-4505-97BA-ED4C04DA9613Q42097305-6B6E6EA3-2375-4E96-9919-0F2C1B675FDBQ42137226-FF9DBC50-8A45-43B8-B751-8CC4E829EC7CQ42580316-AC174996-322D-4A16-B356-7332E5BA5C82Q46314923-6381CB3D-4609-4FC4-AB88-93733DE25B7CQ46772238-533A12E5-740C-4C19-B3C8-6D7D44112256Q46830133-502C70FE-D87A-4E68-8A4A-906B9849AEB8Q46866287-650CC162-BDDD-4FE2-8EB4-942415A01037Q47096434-A145A6E6-66D0-4E53-803A-81895B49AE39Q48139249-CAD85726-F3E4-427D-9619-5A010F11B924Q51732549-F45F7224-65B4-435C-A9B8-38640C21306E
P2860
Modulation of SIRT1 expression in different neurodegenerative models and human pathologies
description
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juli 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/07/17)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/07/17)
@nl
наукова стаття, опублікована в липні 2008
@uk
مقالة علمية (نشرت في 17-7-2008)
@ar
name
Modulation of SIRT1 expression ...... e models and human pathologies
@ast
Modulation of SIRT1 expression ...... e models and human pathologies
@en
Modulation of SIRT1 expression ...... e models and human pathologies
@nl
type
label
Modulation of SIRT1 expression ...... e models and human pathologies
@ast
Modulation of SIRT1 expression ...... e models and human pathologies
@en
Modulation of SIRT1 expression ...... e models and human pathologies
@nl
prefLabel
Modulation of SIRT1 expression ...... e models and human pathologies
@ast
Modulation of SIRT1 expression ...... e models and human pathologies
@en
Modulation of SIRT1 expression ...... e models and human pathologies
@nl
P2093
P50
P921
P3181
P1433
P1476
Modulation of SIRT1 expression ...... e models and human pathologies
@en
P2093
A. M. Canudas
M. Yeste-Velasco
P304
P3181
P356
10.1016/J.NEUROSCIENCE.2008.04.065
P4011
a515aa7360c69fa71b08cfc161853eae6bff3584
P407
P50
P577
2008-07-17T00:00:00Z